지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2017.1
- 수록면
- 213 - 217 (5page)
이용수
초록· 키워드
오류제보하기
This regulatory post-marketing surveillance study aimed to evaluate the therapeutic efficacy and safety of drospirenone (DRSP) 2 mg/estradiol (E2) 1 mg tablet in Korean postmenopausal women. A total of 4,149 patients were enrolled and the study was conducted at 207 clinical research centers. The patients’ source data was collected between November 2006 and November 2012. More than 85% of patients experienced improvement of menopausal symptoms. The most frequently reported adverse events were vaginal bleeding and breast pain; most of the women suffering from these symptoms fully recovered. The incidence of adverse event was higher in patients of younger age (20 to 39 years), in patients with concomitant diseases, previous hormone replacement therapy in medical history, those treated with DRSP 2 mg/E2 1 mg for shorter duration (3 years or less) and in patients using concomitant medication. In conclusion, the results from this large post-marketing surveillance study confirm the efficacy and safety of DRSP 2 mg/E2 1 mg tablet in Korean postmenopausal women.
목차
등록된 정보가 없습니다.
참고문헌 (13)
참고문헌 신청
Archer DF / 2005 / Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial / Menopause 12 : 716 ~ 727
Archer DF / 2007 / Drospirenone and estradiol: a new option for the postmenopausal woman / Climacteric 10 (1) : 3 ~ 10
Fuhrmann U / 1996 / The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential / Contraception 54 : 243 ~ 251
Krattenmacher R. / 2000 / Drospirenone: pharmacology and pharmacokinetics of a unique progestogen / Contraception 62 : 29 ~ 38
Lee BS / 2007 / Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter
Archer DF / 2007 / Drospirenone and estradiol: a new option for the postmenopausal woman / Climacteric 10 (1) : 3 ~ 10
Fuhrmann U / 1996 / The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential / Contraception 54 : 243 ~ 251
Krattenmacher R. / 2000 / Drospirenone: pharmacology and pharmacokinetics of a unique progestogen / Contraception 62 : 29 ~ 38
Lee BS / 2007 / Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
Obstetrics & Gynecology Science
2024 .07
-
The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients
Journal of Gynecologic Oncology
2018 .01
-
Observational Study for Adverse Effects and Discontinuation with Long-Term Post-Operative Hormonal Treatment for Endometriosis in Real-World Practice
고신대학교 의과대학 학술지
2021 .12
-
The Epidemiology of Myasthenia Gravis in Korea
Yonsei Medical Journal
2016 .01
-
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
Diabetes and Metabolism Journal
2017 .01
-
Cell Therapy Products in Menopausal Medicine
대한폐경학회지
2016 .01
-
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Cancer Research and Treatment
2023 .01
-
근무력증 위기를 겪은 중증근무력증 환자의 한의학적 중재에 관한 증례보고 1례
대한한방내과학회지
2022 .05
-
Effectiveness and safety of sorafenib 400 mg vs. 800 mg initial dose on survival in patients with advanced and intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
Gut and Liver
2024 .01
-
Association of periodontitis with menopause and hormone replacement therapy: a hospital cohort study using a common data model
Journal of Periodontal & Implant Science
2023 .06
-
Perceptions of Postmenopausal Symptoms and Treatment Options among Middle-Aged Korean Women
Yonsei Medical Journal
2017 .01
-
The Role of Menopausal Hormone thrapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis
대한폐경학회지
2018 .01
-
Comparing the Pattern of Menopausal Symptoms, Concern and Attitudes in Urban and Rural Postmenopausal Iranian Women
대한폐경학회지
2018 .01
-
Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
지질·동맥경화학회지
2020 .01
-
포커스 그룹 인터뷰를 이용한 환자안전전담자의 환자 및 보호자 대상 환자 안전 교육 경험 분석
한국의료질향상학회지
2019 .01
-
의과대학생을 위한 환자안전 교육의 국제적 동향 및 국내 현황
의학교육논단
2019 .01
-
중증근무력증이 한의학적 치료로 개선된 임상 1례
대한한방내과학회지
2019 .01
-
Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis
Obstetrics & Gynecology Science
2016 .01
-
Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study
Yonsei Medical Journal
2017 .07
이 논문의 저자 정보
최근 본 자료
댓글(0)
0